109
Views
0
CrossRef citations to date
0
Altmetric
Research Article

CD4+ CD25+ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model

, , , &
Pages 835-847 | Received 01 Jul 2010, Accepted 06 Mar 2011, Published online: 21 Apr 2011
 

Abstract

Background aims. Behcet's disease (BD) is a chronic, multisystemic inflammatory disorder with arthritic, gastrointestinal, mucocutaneous, ocular, vascular and central nervous system involvement. It is well known that CD4+ CD25+ T-regulatory (Treg) cells prevent harmful immune responses to self- and non-self-antigens. In the present study, the role of Treg cells in herpes simplex virus (HSV)-induced BD-like symptoms was investigated. Methods. HSV type 1 (F strain) inoculation of the earlobe of ICR mice has been shown to induce the development of BD-like symptoms. To determine whether the effect of Treg was associated with change in BD-like symptoms, CD4+ CD25+ T cells from the splenocytes of normal mice were adoptively transferred intravenously. Treg cells of splenocytes were significantly elevated following the transfer of 3 × 105 CD4+ CD25+ T cells to BD-like mice compared with the control group. Results. The transfer of CD4+ CD25+ T cells to BD mice improved the symptoms, and the serum protein levels of interleukin (IL)-10, IL-6 and IL-17 were significantly altered compared with the control groups. Intravenous injection of anti-CD25 antibody to BD mice reduced the frequency of CD4+ CD25+ T cells and increased the BD severity score. We confirmed the influence of CD4+ CD25+ T cells on BD-like mice. Conclusions. These results show that up-regulation of the CD4+ CD25+ T cells in BD-like mice improves the inflammatory symptoms, while down-regulation of CD25+ T cells is associated with deteriorated symptoms. Furthermore, these findings are correlated with changes in pro-inflammatory and anti-inflammatory cytokine levels.

Acknowledgments

This work was supported by the Korea Research Foundation Grant (MOEHRD, Basic Research Promotion Fund) (KRF-2007-313-E00349) and the Korean Health Technology R&D Project, Ministry for Health, Welfare &Family Affairs, Republic of Korea (A100535).

Declaration of interest: The authors have no competing interests to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.